Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of 9-Aminocamptothecin in Hodgkin's Disease and Non-Hodgkin's Lymphoma
NCT00002745Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Apr 1996
- Primary completion
- Apr 2003
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of 9-aminocamptothecin in Hodgkin lymphoma (HL), non-Hodgkin lymphoma (NHL), sponsored by National Cancer Institute. Started Apr 1996; status: completed.
02
Drugs
9-aminocamptothecin
03
Conditions
Hodgkin lymphoma (HL)non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00002745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002745.